Reports on Arteriovenous Malformations Findings from Hallym University College of Medicine Provide New Insights (Danazol as a Treatment for Uterine Arteriovenous Malformation: A Case Report).

According to news originating from Seoul, South Korea, by NewsRx correspondents, research stated, "Uterine arteriovenous malformation (AVM) is associated with a risk of massive uterine bleeding. Of two patients who developed AVM after a cesarean section, one experienced AVM reduction, and the other developed massive bleeding, requiring emergency uterine artery embolization. Keywords: Angiology; Antigonadotropic Agents; Arteriovenous Malformation; Arteriovenous Malformations; Cardiovascular Abnormalities; Cardiovascular Diseases and Conditions; Cesarean Section; Congenital Abnormalities; Danazol Therapy; Drugs and Therapies; Embolization; Gynecology; Health and Medicine; Hormones; Obstetrics; Pharmaceuticals; Pregnancy; Surgery; Surgical Procedures; Uterine Artery; Uterine Artery Embolization; Vascular Malformations; Women's Health EN Angiology Antigonadotropic Agents Arteriovenous Malformation Arteriovenous Malformations Cardiovascular Abnormalities Cardiovascular Diseases and Conditions Cesarean Section Congenital Abnormalities Danazol Therapy Drugs and Therapies Embolization Gynecology Health and Medicine Hormones Obstetrics Pharmaceuticals Pregnancy Surgery Surgical Procedures Uterine Artery Uterine Artery Embolization Vascular Malformations Women's Health 890 890 1 09/11/23 20230912 NES 230912 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in arteriovenous malformations. [Extracted from the article]